Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - pentamidine isetionate -

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - ketamine hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - amikacin -

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - vincristine sulfate, quantity: 1 mg/ml - injection - excipient ingredients: water for injections; mannitol; sodium hydroxide; sulfuric acid - vincristine sulfate injection is indicated in acute leukemia. vincristine sulfate injection has also been shown to be useful in combination with other oncolytic agents in hodgkin's disease, non-hodgkin's malignant lymphomas (lymphocytic, mixed cell, histiocytic, undifferentiated, nodular and diffuse types), rhabdomyosarcoma, neuroblastoma, and wilm's tumor.

Canada - English - Health Canada

hospira healthcare ulc - piperacillin (piperacillin sodium) - powder for solution - 2g - piperacillin (piperacillin sodium) 2g - extended-spectrum penicillins

Canada - English - Health Canada

hospira healthcare ulc - piperacillin (piperacillin sodium) - powder for solution - 3g - piperacillin (piperacillin sodium) 3g - extended-spectrum penicillins

Canada - English - Health Canada

hospira healthcare ulc - piperacillin (piperacillin sodium) - powder for solution - 4g - piperacillin (piperacillin sodium) 4g - extended-spectrum penicillins

European Union - English - EMA (European Medicines Agency)

pfizer europe ma eeig - bortezomib - multiple myeloma - other antineoplastic agents - bortezomib hospira as monotherapy or in combination with pegylated liposomal doxorubicin or dexamethasone is indicated for the treatment of adult patients with progressive multiple myeloma who have received at least 1 prior therapy and who have already undergone or are unsuitable for haematopoietic stem cell transplantation.bortezomib hospira in combination with melphalan and prednisone is indicated for the treatment of adult patients with previously untreated multiple myeloma who are not eligible for high-dose chemotherapy with haematopoietic stem cell transplantation.bortezomib hospira in combination with dexamethasone, or with dexamethasone and thalidomide, is indicated for the induction treatment of adult patients with previously untreated multiple myeloma who are eligible for high-dose chemotherapy with haematopoietic stem cell transplantation.bortezomib hospira in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma who are unsuitable for haematopoietic stem cell transplantation.

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - cisplatin, quantity: 1 mg/ml - injection, intravenous infusion - excipient ingredients: hydrochloric acid; water for injections; sodium hydroxide; sodium chloride; mannitol - cancer chemotherapeutic drug - details of indications do not appear in the leaflet as exported from hospira australia

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - cisplatin, quantity: 1 mg/ml - injection - excipient ingredients: sodium hydroxide; hydrochloric acid; sodium chloride; mannitol; water for injections - cancer chemotherapeutic drug - details of the indications do not appear on the leaflet as exported from hospira australia